Requip 2mg. 4mg. 8mg Tablets
PDF Leaflet Revision Date: 06 September 2018
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Parkinsonu2019s Disease.
Dosage (summary)
Initial: 2 mg once daily, titrate as needed up to 24 mg.
Onset of Action / Duration
Onset: 6 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- CYP1A2 inhibitors
- Neuroleptics
- CNS depressants
Contraindications
- Hypersensitivity to ropinirole
- Severe renal impairment
- Pregnancy
- Lactation
Common side effects
- Somnolence
- Dizziness
- Nausea
- Hypotension
Counselling Points
- Avoid driving until effects are known
- Monitor for drowsiness
- Gradual dose adjustment recommended
Serious warnings
- Risk of sudden sleep episodes
- Impulse control disorders
- Postural hypotension
Important Disclaimer
The Requip 2mg. 4mg. 8mg Tablets professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
